John McEwen
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 5
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions 10
-
- Diabetes Treatment and Management 4
- Pharmaceutical Science top 5%
- Urology top 5%
-
- Pharmaceutical studies and practices 9
- Pharmacological Effects and Toxicity Studies 5
-
- Pharmaceutical Practices and Patient Outcomes 9
-
- Analytical Methods in Pharmaceuticals 6
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Co-authors
- Anna Lindholm OlinderA. RiisD S HewickDavid HenryKeith YatesAndrew DawsonT. A. MorelandMartin C. Michel
- Journals
- British Journal of Clinical Pharmacology (11 papers)The Medical Journal of Australia (8 papers)Drug Safety (6 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
John McEwen
70 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 138
- Pharmacology 234
- Toxicology 71
- Endocrinology, Diabetes and Metabolism 252
- Pharmaceutical Science 74
- Urology 78
Countries citing papers authored by John McEwen
This map shows the geographic impact of John McEwen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John McEwen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John McEwen more than expected).
Fields of papers citing papers by John McEwen
This network shows the impact of papers produced by John McEwen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John McEwen. The network helps show where John McEwen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John McEwen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 4 | |
| 2 | 2021 | 8 | |
| 3 | 2018 | 20 | |
| 4 | 2014 | 34 | |
| 5 | 2013 | 0 | |
| 6 | 2012 | 11 | |
| 7 | 2008 | 2 | |
| 8 | 2004 | 9 | |
| 9 | [A relative bioavailability study of 2 oral formulations of omeprazole after their administration in repeated doses to healthy volunteers]. | 1999 | 2 |
| 10 | 1998 | 80 | |
| 11 | 1997 | 4 | |
| 12 | 1996 | 4 | |
| 13 | 1992 | 50 | |
| 14 | 1990 | 21 | |
| 15 | 1988 | 8 | |
| 16 | 1988 | 9 | |
| 17 | 1987 | 5 | |
| 18 | 1986 | 15 | |
| 19 | 1983 | 5 | |
| 20 | 1972 | 8 |
About John McEwen
John McEwen is a scholar working on Toxicology, Geriatrics and Gerontology, Pharmacology, Pharmacology and Analytical Chemistry, having authored 73 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Pharmaceutical studies and practices (9 papers), Pharmaceutical Practices and Patient Outcomes (9 papers), Analytical Methods in Pharmaceuticals (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Diabetes Treatment and Management (4 papers). The work is most often cited by research in Pharmacology (234 citations), Toxicology (71 citations), Endocrinology, Diabetes and Metabolism (252 citations), Pharmaceutical Science (74 citations) and Urology (78 citations). John McEwen has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Anna Lindholm Olinder, A. Riis, D S Hewick, David Henry, Keith Yates, Andrew Dawson, T. A. Moreland, Martin C. Michel, Christian de Mey and D. T. Greenwood. Their work appears in journals such as British Journal of Clinical Pharmacology, The Medical Journal of Australia, Drug Safety, Biopharmaceutics & Drug Disposition and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.